MA26540A1 - NEW PROTEASE INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME. - Google Patents

NEW PROTEASE INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.

Info

Publication number
MA26540A1
MA26540A1 MA25238A MA25238A MA26540A1 MA 26540 A1 MA26540 A1 MA 26540A1 MA 25238 A MA25238 A MA 25238A MA 25238 A MA25238 A MA 25238A MA 26540 A1 MA26540 A1 MA 26540A1
Authority
MA
Morocco
Prior art keywords
same
pharmaceutical compositions
compositions containing
protease inhibitor
inhibitor compounds
Prior art date
Application number
MA25238A
Other languages
French (fr)
Inventor
Benjamin Christensen Sigfried
Louise Desjarlais Renee
Jutta Forster Cornelia
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MA26540A1 publication Critical patent/MA26540A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
MA25238A 1997-09-04 1998-09-01 NEW PROTEASE INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME. MA26540A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5752797P 1997-09-04 1997-09-04

Publications (1)

Publication Number Publication Date
MA26540A1 true MA26540A1 (en) 2004-12-20

Family

ID=22011125

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25238A MA26540A1 (en) 1997-09-04 1998-09-01 NEW PROTEASE INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.

Country Status (10)

Country Link
EP (1) EP1015438A4 (en)
JP (1) JP2001514257A (en)
AU (1) AU9300298A (en)
CA (1) CA2302361A1 (en)
CO (1) CO4970736A1 (en)
MA (1) MA26540A1 (en)
PE (1) PE115699A1 (en)
SA (1) SA98190653A (en)
WO (1) WO1999011637A1 (en)
ZA (1) ZA988064B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
JP2003513924A (en) 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション Protease inhibitor
WO2001034599A1 (en) 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
US6583137B1 (en) 1999-11-10 2003-06-24 Smithkline Beecham Corporation Protease inhibitors
CN1416346A (en) 2000-03-21 2003-05-07 史密丝克莱恩比彻姆公司 Peotease inhibitors
WO2002083863A2 (en) 2001-04-17 2002-10-24 Sepracor, Inc. Thiazole and other heterocyclic ligands and use thereof
EP1465862A1 (en) 2002-01-17 2004-10-13 SmithKline Beecham Corporation Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors
KR100962972B1 (en) 2002-07-26 2010-06-09 주식회사유한양행 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof
DE102004008141A1 (en) 2004-02-19 2005-09-01 Abbott Gmbh & Co. Kg Guanidine compounds and their use as binding partners for 5-HT5 receptors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59225172A (en) * 1983-06-03 1984-12-18 Yamanouchi Pharmaceut Co Ltd Novel guanidinothiazole derivative and its preparation

Also Published As

Publication number Publication date
AU9300298A (en) 1999-03-22
EP1015438A1 (en) 2000-07-05
EP1015438A4 (en) 2000-11-08
JP2001514257A (en) 2001-09-11
CO4970736A1 (en) 2000-11-07
PE115699A1 (en) 2000-01-13
CA2302361A1 (en) 1999-03-11
WO1999011637A1 (en) 1999-03-11
ZA988064B (en) 1999-05-28
SA98190653A (en) 2005-12-03

Similar Documents

Publication Publication Date Title
DZ2086A1 (en) Substituted benzylaminopiperidines and pharmaceutical compositions containing them.
MA26492A1 (en) NOVEL PROTEASE INHIBITORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
BR9712544B1 (en) SERINE PROTEASE INHIBITORS, PHARMACEUTICAL COMPOSITION UNDERSTANDING THE SAME AND ITS USES
HUP0104768A3 (en) 4-amino-3-oxo-azepanes as protease inhibitors and pharmaceutical compositions containing the same
PT1025241E (en) CLEANING COMPOSITIONS CONTAINING MULTIPLAMENTLY SUBSTITUTED PROTEASE VARIANTS AND AMYLASE VARIANTS
DZ2964A1 (en) New substituted diphenylureas, and pharmaceutical compositions containing them.
MA26491A1 (en) SELECTIVE COX-2 INHIBITOR COMPOUNDS, ANTI-INFLAMMATORY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
DZ2494A1 (en) Pharmaceutical composition of omeprazole.
MA26537A1 (en) NOVEL 2-AMINOPYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
BR9509729A (en) Detergent compositions containing lipase and protease
HUP0103806A2 (en) Serine protease inhibitor and pharmaceutical compositions containing them
BR9611184B8 (en) COMPOUND AND COMPOSITION.
MA26486A1 (en) PROTEASE INHIBITOR ARYL- AND HETEROARYL-THIAZOLOCETOHYDRAZIDES, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ATE293970T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING LIPASE INHIBITORS
HUP0100669A3 (en) Peptide derivatives as serine protease inhibitors, their use and pharmaceutical compositions comprising thereof
HUP0103283A3 (en) Pyrazinone protease inhibitors, pharmaceutical compositions containing them and use of the compounds
BRPI9810519B1 (en) 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives and pharmaceutical composition comprising the same.
IL138028A0 (en) Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical use
BR9504791B1 (en) polypeptide compound and pharmaceutical composition.
IS2435B (en) Pharmaceutical aerosol composition
HUP0101699A3 (en) Benzoxazinones/benzothiazinones as serine protease inhibitors and pharmaceutical compositions containing the same
NO995434L (en) protease inhibitors
MA26487A1 (en) PROTEASE INHIBITOR HETEROCYCLECETOHYDRAZIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
IL120311A0 (en) Serine protease inhibitors and pharmaceutical compositions containing them
HUP9900390A3 (en) Serine protease inhibitors, and pharmaceutical compositions containing them